Sirnaomics Ltd banner
S

Sirnaomics Ltd
HKEX:2257

Watchlist Manager
Sirnaomics Ltd
HKEX:2257
Watchlist
Price: 7.63 HKD -4.63% Market Closed
Market Cap: HK$810.5m

Relative Value

The Relative Value of one Sirnaomics Ltd stock under the Base Case scenario is hidden HKD. Compared to the current market price of 7.63 HKD, Sirnaomics Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Sirnaomics Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

Competitors Multiples
Sirnaomics Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Sirnaomics Ltd
HKEX:2257
802.4m HKD 57.8 -7.3 -13.2 -13.2
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 643 258.8 -159 901.4 -194 171.3 -191 955.6
US
Abbvie Inc
NYSE:ABBV
387.4B USD 6.6 168.3 16.3 23.1
US
Amgen Inc
NASDAQ:AMGN
201.5B USD 5.5 26.2 15 15
US
Gilead Sciences Inc
NASDAQ:GILD
186.3B USD 6.4 23 15.7 15.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
117.8B USD 10.2 32.6 24 25
US
Epizyme Inc
F:EPE
94.1B EUR 2 094 -534.3 -581.8 -566.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.5B USD 5.7 18.1 15.4 17.6
AU
CSL Ltd
ASX:CSL
87.1B AUD 3.9 20.2 13.5 16.8
NL
argenx SE
XBRU:ARGX
41.9B EUR 14 32.9 56 57.6
US
Seagen Inc
F:SGT
39.3B EUR 20.2 -61.8 -66.7 -60.2
P/S Multiple
Revenue Growth P/S to Growth
US
S
Sirnaomics Ltd
HKEX:2257
Average P/S: 3 058 680.3
57.8
456%
0.1
FR
Pharnext SCA
OTC:PNEXF
33 643 258.8
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.6
9%
0.7
US
Amgen Inc
NASDAQ:AMGN
5.5
2%
2.8
US
Gilead Sciences Inc
NASDAQ:GILD
6.4
4%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
10.2
10%
1
US
E
Epizyme Inc
F:EPE
2 094
N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.7
8%
0.7
AU
CSL Ltd
ASX:CSL
3.9
5%
0.8
NL
argenx SE
XBRU:ARGX
14
49%
0.3
US
S
Seagen Inc
F:SGT
20.2
30%
0.7
P/E Multiple
Earnings Growth PEG
US
S
Sirnaomics Ltd
HKEX:2257
Average P/E: 45.9
Negative Multiple: -7.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -159 901.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
168.3
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
26.2
18%
1.5
US
Gilead Sciences Inc
NASDAQ:GILD
23
191%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
32.6
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -534.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.1
9%
2
AU
CSL Ltd
ASX:CSL
20.2
11%
1.8
NL
argenx SE
XBRU:ARGX
32.9
42%
0.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.8 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
S
Sirnaomics Ltd
HKEX:2257
Average EV/EBITDA: 22.3
Negative Multiple: -13.2
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 171.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.3
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
15
10%
1.5
US
Gilead Sciences Inc
NASDAQ:GILD
15.7
7%
2.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -581.8 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.4
24%
0.6
AU
CSL Ltd
ASX:CSL
13.5
8%
1.7
NL
argenx SE
XBRU:ARGX
56
810%
0.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -66.7 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
S
Sirnaomics Ltd
HKEX:2257
Average EV/EBIT: 24.4
Negative Multiple: -13.2
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -191 955.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.1
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
15
2%
7.5
US
Gilead Sciences Inc
NASDAQ:GILD
15.7
13%
1.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25
16%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -566.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.6
23%
0.8
AU
CSL Ltd
ASX:CSL
16.8
11%
1.5
NL
argenx SE
XBRU:ARGX
57.6
N/A N/A
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.2 N/A N/A